• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Mauna Kea Technologies

Mauna Kea lands 510(k), CE Mark for next-gen Cellvizio platform

March 5, 2020 By Danielle Kirsh

Mauna Kea (ENT:MKEA) this week said it won FDA clearance and CE Mark approval for its next-generation Cellvizio endomicroscopy platform. The Cellvizio uses modular design solutions to better integrate endomicroscopy in procedure suites and third-party platforms. The new platform was designed to facilitate future developments that include deep learning capabilities for assisted image interpretation. It’s also […]

Filed Under: Imaging Tagged With: Mauna Kea Technologies

FDA clears Mauna Kea Technologies system for lung cancer detection

February 26, 2019 By Nancy Crotti

Paris-based Mauna Kea Technologies (ENT:MKEA) said that it has received  510(k) clearance from FDA for the use of the Cellvizio AQ-Flex 19 Confocal Miniprobe through existing bronchoscopes, transbronchial needles, and other bronchoscopic accessories to detect lung cancer. Cellvizio is a multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform designed to aid clinicians in the diagnosis and treatment […]

Filed Under: 510(k), Diagnostics, Food & Drug Administration (FDA), Imaging, News Well, Oncology, Regulatory/Compliance Tagged With: FDA, Mauna Kea Technologies

Mauna Kea, Cook Medical terminate Cellvizio dev, distro deal

February 21, 2019 By Fink Densford

Mauna Kea (ENT:MKEA) said today that it and Cook Medical have mutually decided to terminate their development and distribution agreement. The deal, originally inked in late 2015, included the development of Mauna Kea’s Cellvizio confocal laser endomicroscopy systems for urologic applications. Paris-based Mauna Kea said that it agreed to develop a private-label version of the Cellvizio […]

Filed Under: Business/Financial News, Featured, Imaging, Urology Tagged With: Cook Medical, Mauna Kea Technologies

7 medtech stories we missed this week: May 25, 2018

May 25, 2018 By Danielle Kirsh

From Mauna Kea receiving FDA clearance to Medacta getting clearance for its pedicle screw placement guide, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Mauna Kea wins FDA nod for neurosurgery indication Mauna Kea announced in a May 24 press release that it has received FDA 510(k) clearance […]

Filed Under: 510(k), Catheters, Diagnostics, Food & Drug Administration (FDA), Imaging, Implants, Patient Monitoring, Regulatory/Compliance Tagged With: Bonesupport, collagenmatrix, crossroadsextremitysystems, Implanet, Mauna Kea Technologies, MC10, Medacta, xablecath

Medtronic taps Harvard cardiologist Mauri for clinical research VP | Personnel Moves – April 10, 2018

April 10, 2018 By Fink Densford

Medtronic (NYSE:MDT) said last week it tapped Harvard Medical School professor and cardiologist Dr. Laura Mauri as its new vice president of global clinical research and analytics. In the new position, Dr. Mauri will direct dynamic global clinical research strategies as well as the development of novel analytical and data science solutions as the Fridley, Minn.-baesd […]

Filed Under: Business/Financial News Tagged With: Avedro Inc., Clarify Medical, GE, Harvard, Henry Schein Medical, Mauna Kea Technologies, Medtronic, milestonescientific, Nemaura Medical, Omnicell Inc., Personnel Moves, Second Sight, Stryker

Mauna Kea wins expanded FDA 510(k) for Cellvizio

December 18, 2017 By Fink Densford

Mauna Kea (ENT:MKEA) said today it won expanded FDA 510(k) clearance for its Cellvizio confocal laser endomicroscopy platform and its Confocal Miniprobe devices. The Cellvizio device is designed for use in a variety of surgical procedures, providing real time visualization at the microscopic level. The system allows the operating physician to visualize the internal microstructure of tissue […]

Filed Under: 510(k), Food & Drug Administration (FDA), Imaging, Regulatory/Compliance Tagged With: Mauna Kea Technologies

Mauna Kea touts Cellvizio pancreatic cyst diagnosis study data

October 30, 2017 By Fink Densford

Mauna Kea (ENT:MKEA) today released data from a study exploring the use of the company’s Cellvizio system to diagnose pancreatic cysts, touting improved diagnoses and patient management. Results from the trial were presented at the United European gastroenterology Week 2017 meeting, the Paris-based company said. The Cellvizio device is designed for use in a variety of […]

Filed Under: Clinical Trials, Imaging, Oncology Tagged With: Mauna Kea Technologies

MRI Interventions taps ex-Philips exec Burnett as prez, CEO | Personnel Moves – Oct 19, 2017

October 19, 2017 By Fink Densford

MRI Interventions (OTC:MRIC) said early this month it tapped former Royal Philips (NYSE:PHG) neuro diagnostics & therapy biz GM Joseph Burnett as its new prez & CEO, effective November 7. Burnett will replace Frank Grillo who will stay in his role until November 6 and will continue to serve as an executive advisor afterwards, the Irvine, Calif.-based […]

Filed Under: Business/Financial News Tagged With: BioSig Technologies, Bluewind Medical, Boston Scientific, Dentsply Sirona, Guidant Corp., InMode Aesthetic Solutions, Johnson and Johnson, Mauna Kea Technologies, mazorrobotics, Medtronic, MRI Interventions, otoharmonics, Philips, Silk Road Medical Inc.

Cook Medical urology biz launches Mauna Kea’s Cellvizio

September 5, 2017 By Fink Densford

UPDATE: Corrected to reflect that the launch was global, and not limited to the US. Cook Medical said today its urology business has launched Mauna Kea‘s (ENT:MKEA) Cellvizio confocal laser endomicroscopy system, with a deal to distribute the device globally. The Cellvizio device is designed for use in a variety of surgical procedures, providing real […]

Filed Under: Distribution, Imaging, Urology Tagged With: Cook Medical, Mauna Kea Technologies

Mauna Kea wins FDA nod for CelioFlex Cellvizio miniprobes

August 7, 2017 By Fink Densford

Mauna Kea (ENT:MKEA) said today it won FDA 510(k) clearance for its CelioFlex UHD confocal miniprobes designed for use with its Cellvizio device in robotic-assisted surgery. The CelioFlex UHD probes are designed to provide visualization of body cavities, organs and canals during endoscopic, laparoscopic and robotic-assisted procedures, the Paris-based company said. “This new FDA clearance is […]

Filed Under: 510(k), Food & Drug Administration (FDA), Imaging, Regulatory/Compliance Tagged With: Mauna Kea Technologies

Mauna Kea touts Cellvizio pancreatic cyst diagnosis data

July 12, 2017 By Fink Densford

Mauna Kea (ENT:MKEA) today touted the results from a recently published study of its Cellvizio system which supported the use of the device in diagnosing pancreatic cysts. The Cellvizio device is designed for use in a variety of surgical procedures, providing real time visualization at the microscopic level, Mauna Kea said. Results from the study were […]

Filed Under: Clinical Trials, Imaging Tagged With: Mauna Kea Technologies

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy